A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
Clinical trial NCT05744466 · RECRUITING
Trial details
- NCT number
- NCT05744466
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-30
- Primary completion
- 2027-12-10
- Enrollment
- 1500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.